Evaluating the health economic impact of cefepime/enmetazobactam in complicated urinary tract infections in the German setting: a cost analysis from payer perspective.
Saved in:
| Title: | Evaluating the health economic impact of cefepime/enmetazobactam in complicated urinary tract infections in the German setting: a cost analysis from payer perspective. |
|---|---|
| Authors: | Röder J; VITIS Healthcare Group, Cologne, Germany., Wingen-Heimann SM; VITIS Healthcare Group, Cologne, Germany.; Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD, Excellence Centre for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany., Seidel D; VITIS Healthcare Group, Cologne, Germany.; Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD, Excellence Centre for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany., Froitzheim AC; VITIS Healthcare Group, Cologne, Germany.; Faculty of Medicine, University Duisburg-Essen, Essen, Germany., Kurte MS; VITIS Healthcare Group, Cologne, Germany.; Faculty of Medicine, University Duisburg-Essen, Essen, Germany., Witzke O; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany., Vehreschild MJGT; Department II of Internal Medicine, Infectious Diseases, Goethe University Frankfurt, University Hospital Frankfurt, Frankfurt Am Main, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt Am Main, Germany., Cornely OA; Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD, Excellence Centre for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany., Kron F; VITIS Healthcare Group, Cologne, Germany. florian.kron@fom.de.; Department I of Internal Medicine/Center for Integrated Oncology (CIO Cologne), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. florian.kron@fom.de.; FOM University of Applied Sciences, Herkulesstraße 32, 45127, Essen, Germany. florian.kron@fom.de. |
| Source: | Infection [Infection] 2026 Apr; Vol. 54 (2), pp. 807-816. Date of Electronic Publication: 2025 Dec 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Heidelberg Country of Publication: Germany NLM ID: 0365307 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-0973 (Electronic) Linking ISSN: 03008126 NLM ISO Abbreviation: Infection Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
